Side effects reported in those taking statins are not actually attributable to the drugs

Investigators call on drug regulators to provide clear evidence to patients on claims of drug side effects

2014-03-13

(Press-News.org) Sophia Antipolis, 13 March 2014. At a time when the wider prescription of statins is under renewed public scrutiny, a substantial analysis of placebo-controlled randomised trials of statins has found that only a small minority of side effects reported by those taking the cholesterol-lowering drugs are actually attributable to them. Almost all the side effects reported in these trials "occurred anyway when patients were administered placebo", say the investigators.

The study, a meta-analysis involving more than 80,000 patients and reported today in the European Journal of Preventive Cardiology, was performed without funding from any agency in the public, commercial or not-for-profit sectors.(1)

Explaining the need for such a study, the authors note that evaluation of the efficacy of statins is always based on the evidence of randomised controlled trials (RCTs) against placebo, while the evaluation of side effects is not. Adverse events listed for statins come from many sources, they note, including observational studies, in which most are unable to differentiate between events caused by the drug or caused by chance.

"Patients and doctors need clear reliable information about benefits and risks to make informed decisions," they write, adding that those reporting symptomatic side effects during statin therapy need reliable confirmation that a symptom is truly caused by the drug.

This study analysed the prevalence of side effects in 29 eligible RCTs performed for the primary (46,262 participants) and secondary (37,618) prevention of cardiovascular disease. Data on all adverse effects, cardiovascular events and death were recorded in both the treatment and control (placebo) arms of the studies. Using a statistical model, the investigators calculated the increase in risk for each side effect in the statin and placebo arms.

Among a long list of side effects assessed - which included nausea, renal disorder, myopathy and rhabdomyolysis (muscle breakdown), muscle ache, insomnia, fatigue, and gastrointestinal disturbance - only the risk of new onset diabetes mellitus was increased by statin therapy.

In the 14 primary prevention trials, randomisation to statins rather than placebo significantly increased the prevalence of diabetes by 0.5% (and similarly reduced mortality rate by 0.5%). And across both primary and secondary prevention trials, the rate of developing diabetes with statins was 3%, against 2.4% with placebo, thus indicating that around one in five of new cases of diabetes was actually caused by statins.

Otherwise, the authors report, the many side effects commonly attributed to statins (notably myopathy, fatigue, muscle aches, and rhabdomyolysis) were no more common in the statin arms of these RCTs than in the placebo arms.

Overall, the study found serious adverse effects in 14.6% of patients receiving statins and 14.9% given placebo in the primary prevention trials, and in 9.9% of those on statins and 11.2% on placebo in the secondary prevention trials. Similarly, comparable numbers of patients withdrew from the trials because of symptomatic adverse events (around 12-15%).

In their bid to provide doctors with a clear estimate of the risk of side effects genuinely attributable to statins, the investigators have calculated a "clear, understandable metric for everyday clinical use" - the proportion of side effects not attributable to their pharmacological action, or PSN.

Thus, in the diabetes risk noted above, 20% (0.6/3.0) of all new diabetes diagnoses on statins were directly attributable to the drugs, giving a PSN of 80.

Despite the findings, the authors acknowledge that many real-world patients do report symptoms with statins - which of course contrasts markedly with their results. In explaining this, the study's first author, Dr Judith Finegold from the National Heart and Lung Institute in London, says: "We clearly found that many patients in these trials - whose patients are usually well motivated volunteers who didn't know if they were getting a real or placebo tablet - that many did report side effects while taking placebo. In the general population, where patients are being prescribed a statin for an asymptomatic condition, why would it be surprising that even higher rates of side effects are reported?

"Most people in the general population, if you repeatedly ask them a detailed questionnaire, will not feel perfectly well in every way on every day. Why should they suddenly feel well when taking a tablet after being warned of possible adverse effects?"

Asked if the study results add weight to the case for the wider prescription of statins, Dr Finegold said: " No, we think that our results will help improve the patient-doctor consultation. We believe that patients should be empowered to make their own decisions, but we must first make sure they have top quality unbiased information. This is why we call on drug regulators to highlight in the long lists of side effects those few whose rate is incrementally greater than that experienced with a dummy tablet."

INFORMATION: END

ELSE PRESS RELEASES FROM THIS DATE:

Purified fish oils could help treat rare disease affecting newborn babies

2014-03-13

A rare and potentially lethal disease of newborn babies whose bodies make too much insulin may be treatable with fish oils, according to researchers from The University of Manchester. The disease, called congenital hyperinsulinism, means that the infant's brain is starved of blood sugar which can lead to brain damage or long-term disability. But by giving the children purified fish oils similar to those used to treat some heart attack patients, alongside standard medical treatment, their blood sugar levels improve, the researchers reported today in the open-access journal ...

Estradiol preserves key brain regions in postmenopausal women at risk for dementia

2014-03-12

STANFORD, Calif. — When initiated soon after menopause, hormone therapy with estradiol prevented degeneration in key brain regions of women who were at heightened dementia risk, according to a new study led by Stanford University School of Medicine researchers. The investigators also found that another type of hormone therapy, marketed under the brand name Premarin, was far less protective. Premarin is a mixture of 30-plus substances derived from the urine of pregnant mares. Estradiol — the dominant sex-steroid hormone in woman — accounts for about 17 percent of Premarin's ...

Language 'evolution' may shed light on human migration out-of-Beringia

2014-03-12

Evolutionary analysis applied to the relationship between North American and Central Siberian languages may indicate that people moved out from the Bering Land Bridge, with some migrating back to central Asia and others into North America, according to a paper published in the open-access journal PLOS ONE on March 12, 2014 by Mark Sicoli, from Georgetown University and Gary Holton from University of Alaska Fairbanks. Languages evolve slowly overtime and may even follow human migratory patterns. A proposed language family known as the Dené–Yeniseian suggests that there ...

Review of home care visits for the elderly finds there is 'no proven benefit'

2014-03-12

In what's thought to be the biggest review of academic literature into whether home care visits provide benefits for the elderly, researchers conclude there is 'no consistent evidence' to show they lead to the elderly living longer or having more independent lives than those without any visits. Researchers from University College London (UCL) and the University of Oxford analysed 64 randomised controlled trials (RCTs), mainly in the United States, Canada and the UK. They say that they cannot rule out the possibility that some programmes involving home care visits may be ...

Europe's resilience of natural gas networks during conflicts and crises probed with maths

2014-03-12

Gas networks in Eastern European countries, such as Ukraine and Belarus are less resilient than the UK during conflicts and crises, according to new research from mathematicians at Queen Mary University of London. The authors suggest that a decentralised approach to managing congestion on gas pipeline networks could be crucial for energy security during geopolitical conflicts or natural disasters, for example. "Natural gas accounts for 24 per cent of energy consumption in Europe*," said co-author Professor David Arrowsmith from Queen Mary's School of Mathematical Sciences. "Nations ...

Dinosaur skull may reveal T. rex's smaller cousin from the north

2014-03-12

A 70 million year old fossil found in the Late Cretaceous sediments of Alaska reveals a new small tyrannosaur, according to a paper published in the open-access journal PLOS ONE on March 12, 2014 by co-authors Anthony Fiorillo and Ronald S. Tykoski from Perot Museum of Nature and Science, Texas, and colleagues. Tyrannosaurs, the lineage of carnivorous theropod ("beast feet") dinosaurs that include T. rex, have captivated our attention, but the majority of our knowledge about this group comes from fossils from low- to mid-latitudes of North America and Asia. In this study, ...

Doctors issue new treatment guidelines for skin abscesses caused by MRSA

2014-03-12

It has been more than 10 years since the clinical battle began with community-acquired methicillin-resistant Staphylococcus aureus (MRSA), and doctors are still grappling with how to diagnose, treat and prevent this virulent form of staph infection, which is immune to many antibiotics. As MRSA cases have increased dramatically over the decade, so have the number of skin abscesses — generally pus-filled boils or pimples with discharge — that characterize these infections. Now, researchers from UCLA have issued updated guidelines outlining the best ways to treat and manage ...

Facebook feelings are contagious

2014-03-12

You can't catch a cold from a friend online. But can you catch a mood? It would seem so, according to new research from the University of California, San Diego. Published in PLOS ONE, the study analyzes over a billion anonymized status updates among more than 100 million users of Facebook in the United States. Positive posts beget positive posts, the study finds, and negative posts beget negative ones, with the positive posts being more influential, or more contagious. "Our study suggests that people are not just choosing other people like themselves to associate with ...

Meta-analysis: Any blood pressure reading above normal may increase risk of stroke

2014-03-12

MINNEAPOLIS – Anyone with blood pressure that's higher than the optimal 120/80 mmHg may be more likely to have a stroke, according to a new meta-analysis published in the March 12, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology. The meta-analysis looked at all of the available research on the risk of developing stroke in people with "prehypertension," or blood pressure higher than optimal but lower than the threshold to be diagnosed with high blood pressure, which is 140/90 mmHg. A total of 19 prospective cohort studies with ...

Gestational diabetes may raise risk for heart disease in midlife

2014-03-12

Pregnant women may face an increased risk of early heart disease when they develop gestational diabetes, according to research in the Journal of the American Heart Association. Gestational diabetes, which develops only during pregnancy and usually disappears after the pregnancy, increases the risk that the mother will develop diabetes later. The condition is managed with meal planning, activity and sometimes insulin or other medications. In the 20-year study, researchers found that a history of gestational diabetes may be a risk factor for early atherosclerosis in women ...

Side effects reported in those taking statins are not actually attributable to the drugs

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: